GZMB and neoplasm: TIL-Bs have various antitumor immune mechanisms, including producing tumor-specific antibodies and inducing antibody-dependent cellular cytotoxicity, inducing tumor apoptosis through granzyme B production, and acting as antigen-presenting cells 34.